Verrica Pharmaceuticals Announces 1-for-10 Reverse Stock Split Effective July 24, 2025

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals (VRCA) filed a Certificate of Amendment to effect a 1-for-10 reverse stock split, authorized by stockholders on June 5, 2025.
The reverse stock split becomes effective at 5:00 p.m. ET on July 24, 2025; trading on Nasdaq on a split-adjusted basis begins July 25, 2025.
Outstanding shares will be reduced from approximately 92.5 million to about 9.25 million, with no fractional shares issued; cash paid in lieu.
Proportionate adjustments will be made to exercise price and number of shares issuable under stock options, warrants, and equity plans.
The new CUSIP number for VRCA common stock post-split is 92511W207.

item 3.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.